v3.25.2
Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Accrued Expenses and Other Current Liabilities [Abstract]    
Accrued research and development expense $ 1,799,583 $ 1,799,583
Accrued directors and officers (owners) compensation 996,675 1,025,867
Cash portion of the Lind Note repayments 769,660 127,759
Accrued compensation and employee benefits 160,914 126,106
Others 564,132 557,866
Total $ 4,290,964 $ 3,509,422